pyridinoline has been researched along with zoledronic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agnello, KA; Budsberg, SC; Chambers, JN; Seewald, W; Trumble, TN | 1 |
| Baccarani, M; Boni, P; Cangini, D; Cavo, M; Ceccolini, M; Cellini, C; Parente, R; Perrone, G; Tacchetti, P; Tosi, P; Tura, S; Zamagni, E | 1 |
| Açil, Y; Behrens, C; Gassling, V; Gierloff, M; Möller, B; Niehoff, P; Simon, M; Wiltfang, J | 1 |
| Açil, Y; Gierloff, M; Gülses, A; Niehoff, P; Reutemann, M; Wiltfang, J | 1 |
| Abraham, P; Awad, ME; Baladhandayutham, B; Elsalanty, ME; Elsayed, R; Kurago, Z; McKenna, CE; Pashley, DH; Whitford, GM | 1 |
2 trial(s) available for pyridinoline and zoledronic acid
| Article | Year |
|---|---|
First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
Topics: Adult; Aged; Alkaline Phosphatase; Amino Acids; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Remodeling; Bone Resorption; Collagen Type I; Dexamethasone; Diphosphonates; Female; Humans; Imidazoles; Male; Middle Aged; Multiple Myeloma; Osteocalcin; Pain; Peptides; Thalidomide; Treatment Outcome; Zoledronic Acid | 2006 |
Effects of zoledronate on the radiation-induced collagen breakdown: a prospective randomized clinical trial.
Topics: Aged; Aged, 80 and over; Amino Acids; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Chemoradiotherapy; Chromatography, High Pressure Liquid; Collagen Type I; Diphosphonates; Female; Humans; Imidazoles; Male; Middle Aged; Radiation Injuries; Radiotherapy; Zoledronic Acid | 2015 |
3 other study(ies) available for pyridinoline and zoledronic acid
| Article | Year |
|---|---|
Effects of zoledronate on markers of bone metabolism and subchondral bone mineral density in dogs with experimentally induced cruciate-deficient osteoarthritis.
Topics: Alkaline Phosphatase; Amino Acids; Analysis of Variance; Animals; Anterior Cruciate Ligament; Bone and Bones; Bone Density; Bone Density Conservation Agents; Diphosphonates; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Imidazoles; Osteoarthritis; Osteocalcin; Time Factors; Tomography, X-Ray Computed; Zoledronic Acid | 2005 |
Effects of zoledronate on irradiated bone in vivo: analysis of the collagen types I, V and their cross-links lysylpyridinoline, hydroxylysylpyridinoline and hydroxyproline.
Topics: Amino Acids; Animals; Bone and Bones; Bone Density Conservation Agents; Chromatography, High Pressure Liquid; Collagen Type I; Collagen Type V; Diphosphonates; Electrophoresis, Polyacrylamide Gel; Hydroxyproline; Imidazoles; Male; Rats; Rats, Wistar; Zoledronic Acid | 2013 |
Removal of matrix-bound zoledronate prevents post-extraction osteonecrosis of the jaw by rescuing osteoclast function.
Topics: Amino Acids; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone and Bones; Calcium; Cell Differentiation; Cell Proliferation; Chelating Agents; Diphosphonates; Edetic Acid; Humans; Jaw; Mass Spectrometry; Mice; Molar; Osteoclasts; Rats; Rats, Sprague-Dawley; RAW 264.7 Cells; Tooth Extraction; X-Ray Microtomography; Zoledronic Acid | 2018 |